ZANIDATAMAB ZOVODOTIN

IMMUNOGLOBULIN G1, ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 LIGHT CHAIN VARIABLE REGION FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 20-AMINO ACID LINKER) FUSION PROTEIN WITH HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 HEAVY CHAIN VARIABLE REGION FRAGMENT FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 2-AMINO ACID LINKER) FUSION PROTEIN WITH HUMAN FC FRAGMENT, (261->229'),(264->232')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS BIPARATOPIC MONOCLONAL ZW25 .KAPPA.-CHAIN, REDUCED, THIOETHER WITH N-(3-(2-(2-(2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ETHOXY)ETHOXY)ETHOXY)-1-OXOPROPYL)-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((((2R,3R)-3-((2S)-1-((3R,4S,5S)-4-((N,N-DIMETHYL-L-VALYL-L-VALYL)METHYLAMINO)-3-METHOXY-5-METHYL-1-OXOHEPTYL)-2-PYRROLIDINYL)-3-METHOXY-2-METHYL-1-OXOPROPYL)AMINO)SULFONYL)PHENYL)-L-ORNITHINAMIDE IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS ERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2, RECEPTOR TYROSINE PROTEIN KINASE ERBB-2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340)), HUMANIZED MONOCLONAL ANTIBODY, BIPARATOPIC (TARGETING TWO DIFFERENT NON-OVERLAPPING EPITOPES ON ERBB2, ON EXTRACELLULAR DOMAINS 2 (ECD2) AND 4 (ECD4), RESPECTIVELY), CONJUGATED TO AURISTATIN E zanidatamab zovodotin [INN] ZW 49 [WHO-DD]